T-Hub, in partnership with Atal Innovation Mission (AIM), has launched the fifth edition of its AIC T-Hub Healthcare Program. From a competitive pool of over 209 applicants, 20 startups have been selected to participate.
This three-month hybrid program is designed to drive innovation in MedTech, digital health, and healthcare accessibility. It offers startups mentorship, market access, investor engagement, and regulatory guidance. The selected startups include Artyem Care, Bioscafil, Chqup, Cloud Palliative Care, Dag2IL, Epirelief, Dr. DICOM (GLOCAL DIGITAL), Kashi Medicos, Nahush Pharma, Oui Medical, Planytics, Reyansh Technologies, Sigma Mozak, Signel Biomedical, Skinska, Tap Health, thebabyland, TurocratesAI, 365Veda, and Warkas. These startups were chosen based on their proof-of-concept readiness, technological innovation, regulatory preparedness, market potential, and the strength of their teams.
Throughout the program, participants will receive personalized mentorship from industry experts, strategic connections with hospitals and corporations, and exclusive networking opportunities with investors to secure funding and business collaborations. They will also have access to healthcare institutions for real-world validation and pilot studies, ensuring their solutions are clinically viable and market-ready. Additionally, startups will receive crucial guidance on navigating domestic and international healthcare regulations, a key aspect of scaling in this highly regulated industry.
By engaging with venture capitalists, healthcare organizations, and policymakers, the startups will have the chance to form strategic partnerships and secure financial backing. The program prioritizes market access by facilitating introductions to hospitals, corporations, and healthcare institutions to drive adoption and business growth.
Since its launch, AIC T-Hub has supported 53 healthcare startups across four previous cohorts, focusing on MedTech, digital health, and healthcare accessibility. These startups have collectively raised over ₹60.46 crore through investor funding and grants. They have also secured more than 180 market access opportunities with hospitals, corporations, and healthcare institutions while gaining exposure at global healthcare conferences, enhancing their industry presence. Initiatives like Doctors & Hospitals Roundtables have enabled startups to showcase their innovations to key stakeholders, fostering collaboration and adoption.
Looking forward, AIC T-Hub plans to expand clinical validation opportunities through partnerships with hospitals, research labs, and pharmaceutical companies. The program also aims to onboard one or two international startups, introducing them to India’s healthcare ecosystem and encouraging cross-border innovation. Additionally, efforts are underway to strengthen its network of doctors, hospitals, and sector-focused investors to support the success of participating startups.
The program will culminate in a Demo Day and Investor Connect event in June 2025, where startups will pitch their solutions to industry leaders and potential investors.
